0001493152-21-011451.txt : 20210514 0001493152-21-011451.hdr.sgml : 20210514 20210514134617 ACCESSION NUMBER: 0001493152-21-011451 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210514 DATE AS OF CHANGE: 20210514 EFFECTIVENESS DATE: 20210514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HARROW HEALTH, INC. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-399461 FILM NUMBER: 21923538 BUSINESS ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615.733.4731 MAIL ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120301 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 FORMER COMPANY: FORMER CONFORMED NAME: Bywater Resources, Inc DATE OF NAME CHANGE: 20060421 D 1 primary_doc.xml X0708 D LIVE 0001360214 HARROW HEALTH, INC. 102 WOODMONT BLVD. SUITE 610 NASHVILLE TN TENNESSEE 37205 (615) 733-4730 DELAWARE None Imprimis Pharmaceuticals, Inc. TRANSDEL PHARMACEUTICALS INC Bywater Resources, Inc Corporation true Andrew R Boll 102 Woodmont Blvd. Suite 610 Nashville TN TENNESSEE 37205 Executive Officer Mark L Baum 102 Woodmont Blvd. Suite 610 Nashville TN TENNESSEE 37205 Executive Officer R Larry Van Horn 102 Woodmont Blvd. Suite 610 Nashville TN TENNESSEE 37205 Director Robert J Kammer 102 Woodmont Blvd. Suite 610 Nashville TN TENNESSEE 37205 Director Teresa F Sparks 102 Woodmont Blvd. Suite 610 Nashville TN TENNESSEE 37205 Director Richard L Lindstrom 102 Woodmont Blvd. Suite 610 Nashville TN TENNESSEE 37205 Director Pharmaceuticals $25,000,001 - $100,000,000 06b false 2021-05-05 false true false 0 10670000 10670000 0 false 1 0 0 0 false HARROW HEALTH, INC. /s/ Andrew R. Boll Andrew R. Boll Chief Financial Officer 2021-05-14